ACCUSTEM SCIENCES, INC. Financing Cash Flow
ACCUSTEM SCIENCES, INC. (ACUT) reported Financing Cash Flow of $622.02 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $249.57K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $372.45K, a 15.84% increase year-over-year.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$22.82K.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $587.18K, a 181.01% increase year-over-year.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2025 was $859.27K, a 32.68% increase from fiscal 2024.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2024 was $647.63K, a 28.29% decline from fiscal 2023.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2023 was $903.15K, a 64.60% decline from fiscal 2022.
- ACCUSTEM SCIENCES, INC. net cash provided by (used in) financing activities for fiscal 2022 was $2.55M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $622.02K 10-Q · filed 2026-08-14 | $599.21K derived: sum of 3 quarters · filed 2026-08-14 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $372.45K 10-Q · filed 2026-05-15 | $349.63K derived: sum of 2 quarters · filed 2026-05-15 | $936.82K derived: sum of 3 quarters · filed 2026-05-15 | $910.21K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$22.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $564.36K derived: sum of 2 quarters · filed 2026-04-14 | $537.75K derived: sum of 3 quarters · filed 2026-08-14 | $859.27K 10-K · filed 2026-04-14 | ||
| 2025-09-30 | $587.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $560.57K derived: sum of 2 quarters · filed 2026-08-14 | $882.09K 10-Q · filed 2025-11-12 | $849.64K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | -$26.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $294.91K 10-Q · filed 2026-08-14 | $262.46K derived: sum of 3 quarters · filed 2026-08-14 | $471.42K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $321.52K 10-Q · filed 2026-05-15 | $289.07K derived: sum of 2 quarters · filed 2026-05-15 | $498.02K derived: sum of 3 quarters · filed 2026-05-15 | $743.91K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$32.45K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-14 | $176.51K derived: sum of 2 quarters · filed 2026-04-14 | $422.39K derived: sum of 3 quarters · filed 2026-04-14 | $647.63K 10-K · filed 2026-04-14 | ||
| 2024-09-30 | $208.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $454.84K derived: sum of 2 quarters · filed 2025-11-12 | $680.08K 10-Q · filed 2025-11-12 | $925.58K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $245.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $471.12K 10-Q · filed 2025-08-14 | $716.63K derived: sum of 3 quarters · filed 2025-08-14 | $1.02M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $225.24K 10-Q · filed 2025-05-20 | $470.75K derived: sum of 2 quarters · filed 2025-05-20 | $772.72K derived: sum of 3 quarters · filed 2025-05-20 | $1.24M derived: sum of 4 quarters · filed 2025-05-20 | ||
| 2023-12-31 | $245.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-03 | $547.47K derived: sum of 2 quarters · filed 2025-04-03 | $1.01M derived: sum of 3 quarters · filed 2025-04-03 | $903.15K 10-K · filed 2025-04-03 | ||
| 2023-09-30 | $301.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $764.90K derived: sum of 2 quarters · filed 2024-11-18 | $657.64K 10-Q · filed 2024-11-18 | $681.92K derived: sum of 4 quarters · filed 2024-11-18 | ||
| 2023-06-30 | $462.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-09-16 | $355.67K 10-Q · filed 2024-09-16 | $379.95K derived: sum of 3 quarters · filed 2024-09-16 | $285.69K derived: sum of 4 quarters · filed 2024-09-16 | ||
| 2023-03-31 | -$107.25K 10-Q · filed 2024-05-20 | -$82.97K derived: sum of 2 quarters · filed 2024-05-20 | -$177.24K derived: sum of 3 quarters · filed 2024-05-20 | -$437.04K derived: sum of 4 quarters · filed 2024-05-20 | ||
| 2022-12-31 | $24.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$69.99K derived: sum of 2 quarters · filed 2024-03-22 | -$329.79K derived: sum of 3 quarters · filed 2024-03-22 | $2.55M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | -$94.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$354.07K derived: sum of 2 quarters · filed 2023-11-13 | $2.53M 10-Q · filed 2023-11-13 | $2.66M 10-Q · filed 2022-11-08 | ||
| 2022-06-30 | -$259.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.62M 10-Q · filed 2023-08-14 | $2.76M 10-Q · filed 2022-08-12 | |||
| 2022-03-31 | $2.88M 10-Q · filed 2023-05-05 |